Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer

NCT00009763 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: filgrastim
BIOLOGICAL: monoclonal antibody m170
DRUG: cyclosporine
DRUG: paclitaxel
PROCEDURE: peripheral blood stem cell transplantation
RADIATION: yttrium Y 90 monoclonal antibody m170

Sponsor

University of California, Davis